Bristol Myers Squibb (BMY) Receivables - Other (2009 - 2026)
Bristol Myers Squibb (BMY) recorded Receivables - Other of $108 million in Q2 2026, down 93.7% from $1.7 billion a year earlier and down 92.4% from the prior quarter.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Receivables - Other (2009 - 2026) Analysis & Trends
At the end of FY2025, Bristol Myers Squibb reported Receivables - Other of $1.82 billion, up 5.0% from FY2024.
- Annual Receivables - Other has a five-year compound annual growth rate of 7.3% (FY2020 to FY2025).
- Across earlier years, Receivables - Other came in at $1.74 billion in FY2024 (-14.9%), $2.04 billion in FY2023 (+17.5%), $1.74 billion in FY2022 (+24.8%) and $1.39 billion in FY2021 (+8.4%).
- The Q2 2026 figure is the lowest quarterly Receivables - Other in data going back to Q4 2009.
- On a year-over-year basis, Receivables - Other has declined for three consecutive quarters, with an average decline of 20.7% over the last eight quarters.
- Peak year-over-year performance for Receivables - Other in the last five years was growth of 62.4% in Q1 2023, against a decline of 93.7% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.42 billion (Q1 2026), $192 million (Q4 2025) and $1.8 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,158.69 Bn | 1,127.28 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 622.73 Bn | 541.26 Bn | 17.26 Bn |
| 3 | AbbVie | 509.26 Bn | 482.37 Bn | 12.70 Bn |
| 4 | Merck | 365.63 Bn | 320.01 Bn | 12.21 Bn |
| 5 | Novartis Ag | 295.70 Bn | 259.69 Bn | 11.24 Bn |
| 6 | Astrazeneca | 260.09 Bn | 233.78 Bn | 12.86 Bn |
| 7 | Amgen | 234.27 Bn | 189.67 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 192.85 Bn | 167.05 Bn | 6.22 Bn |
| 9 | Pfizer | 170.77 Bn | 117.42 Bn | 10.94 Bn |
| 10 | Bristol Myers Squibb | 124.21 Bn | 75.49 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.00 Mn |
| Mar 31, 2026 | 1.42 Bn |
| Dec 31, 2025 | 192.00 Mn |
| Sep 30, 2025 | 1.80 Bn |
| Jun 30, 2025 | 1.70 Bn |
| Mar 31, 2025 | 1.74 Bn |
| Dec 31, 2024 | 385.00 Mn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.68 Bn |
| Mar 31, 2024 | 1.62 Bn |
| Dec 31, 2023 | 416.00 Mn |
| Sep 30, 2023 | 1.90 Bn |
| Jun 30, 2023 | 1.99 Bn |
| Mar 31, 2023 | 2.20 Bn |
| Dec 31, 2022 | 504.00 Mn |
| Sep 30, 2022 | 1.59 Bn |
| Jun 30, 2022 | 1.47 Bn |
| Mar 31, 2022 | 1.36 Bn |
| Dec 31, 2021 | 361.00 Mn |
| Sep 30, 2021 | 1.37 Bn |
API Access
Bristol Myers Squibb Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();